Scemblix 40 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LK4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,782
Award facts
- Contract value 100% obligated
- $79,781.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $79,781.65 to AmerisourceBergen Drug Corp for the supply of Scemblix 40 mg tablets in quantities of 60 units. The contract, which is a firm fixed-price delivery order with no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00 and extending through December 2026, serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The pharmaceutical products supplied under this contract support critical medical needs across the Department of Defense healthcare system, including military treatment facilities and veteran healthcare programs.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs. The company operates as a subsidiary of Cencora, Inc., which holds the parent IDC with DLA. The delivery order is scheduled for completion by February 6, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Scemblix is a specialized oncology medication, consistent with AmerisourceBergen's extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains that it routinely delivers to federal health agencies.
Quick answers
Who was awarded contract SPE2DR26F9LK4?
SPE2DR26F9LK4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9LK4 worth?
The government has obligated $79,782 on SPE2DR26F9LK4.
Is contract SPE2DR26F9LK4 an order under another contract?
Yes. SPE2DR26F9LK4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LK4 competed?
The extent of competition for SPE2DR26F9LK4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award